Atsunobu Sagara
Shibuya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Concerns and Consultation Needs for Hospital and Community Pharmacists at Metastatic or Recurrent Cancer Diagnosis: A Web-Based Survey in Japan.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: August 03, 2026
Relationship of pre-diagnosis pharmacist continuity with patient-reported satisfaction at the first post-diagnosis community pharmacy visit among adolescents and young adults with cancer: a nationwide cross-sectional online survey.
Journal: Journal of pharmaceutical health care and sciences
Published: March 25, 2026
A Cross-sectional Exploratory Study on Symptom Correlations in Multiple Myeloma Patients During Initial Treatment Using the Edmonton Symptom Assessment System.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: March 01, 2026
Experience-based ambivalence toward medical opioid use among Japanese adults: a nationwide cross-sectional survey using the barriers questionnaire II.
Journal: Journal of pharmaceutical health care and sciences
Published: October 26, 2025
Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study.
Journal: Journal of pharmaceutical health care and sciences
Published: October 19, 2025
Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways.
Journal: Oncology reports
Published: September 10, 2025
Pharmacist Awareness, Knowledge, and Clinical Engagement of Medication-Related Osteonecrosis of the Jaw: A Survey From a Designated Community Cancer Care Hospital.
Journal: Cureus
Published: September 09, 2025
Cross-sectional survey on cancer patients' concerns and consultation needs with pharmacists at the time of initial diagnosis.
Journal: Journal of pharmaceutical health care and sciences
Published: May 25, 2025
Safety study on switching from intravenous to fixed‑dose subcutaneous formulation of pertuzumab and trastuzumab.
Journal: Molecular and clinical oncology
Published: November 12, 2024
Infusion Reactions in HER2-Positive Gastric Cancer: Switching from Trastuzumab to Its Biosimilar.
Journal: Biological & pharmaceutical bulletin
Published: August 21, 2024
Usefulness of driver's eye movement measurement to detect potential risks under combined conditions of taking second-generation antihistamines and calling tasks.
Journal: Journal of pharmaceutical health care and sciences
Published: July 05, 2024
Evaluation of the Simple Suspension Method for Oral Anticancer Drugs.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: March 31, 2024
Last Updated: 09/26/2026